- The Russian medical journal published data on the possibility of using pentoxifylline in the complex therapy of COVID-19 to prevent thrombosis. With SARS-CoV-2 virus in patients with a severe course of the disease, multiple thrombi are detected in the vessels of various organs, primarily in the lungs, therefore, according to experts of the journal, patients with pneumonia caused by coronavirus need early anticoagulant and antiplatelet therapy, including expediency of prescribing "antiplatelet agents of erythrocyte orientation (prolonged forms of pentoxifylline)".
- The interdisciplinary group of scientists includes researchers from the departments of metal forming, inorganic chemistry, biochemistry, biotechnology and bioengineering, as well as students. In addition, scientists from Bashkir State Medical University and scientists from Tatarstan and the Moscow Region were involved in research.
- Rodenko N.A., Belyaeva I.A., Vasilyeva T.I. et al. Changes in the activity of various platelet antiplatelet agents upon irradiation with a high-intensity pulsed magnetic field // Butlerov Communications. - 2019.- T. 59. No. 9. - S. 117-124.
- Rodenko N.A., Vasilieva T.I., Belyaeva I.A. The possibility of using drugs after exposure to a pulsed magnetic field of high tension // Actual problems of biological physics and chemistry. - 2019. - T. 4. No. 1. - S. 102-106.